Skip to main content
SpringerLink
Log in

Neuer Standard bei Brustkrebs und PIK3-Mutation

OS-Daten zum PIK3-Inhibitor Alpelisib

  • Info Pharm
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. - Journalistenbüro -, Woensamstr. 7, 50931, Köln, Deutschland

    Nicola Siegmund-Schultze

Authors
  1. Nicola Siegmund-Schultze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Siegmund-Schultze.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siegmund-Schultze, N. OS-Daten zum PIK3-Inhibitor Alpelisib. InFo Hämatol Onkol 24, 57–59 (2021). https://doi.org/10.1007/s15004-021-8633-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8633-7

Search

Navigation